Faites connaître cette offre !
Reference : UMR9198-JOAMEN-005
Workplace : GIF SUR YVETTE,GIF SUR YVETTE
Date of publication : Friday, October 16, 2020
Type of Contract : FTC Scientist
Contract Period : 12 months
Expected date of employment : 1 February 2021
Proportion of work : Full time
Remuneration : 2730 to 3890 euros gross per month depending of the experience
Desired level of education : PhD
Experience required : Indifferent
The postdoctoral researcher will work in a project combining parasitology, proteomics and biochemistry, as part of a new ATIP-Avenir team at the genome biology department of the I2BC (UMR9198). The goal of the project is to determine how two essential nuclear proteins from the malaria parasite, Plasmodium falciparum, interact to then design protein complex inhibitors. The postdoc will collaborate with two teams, one from the I2BC and one from IPSIT, to reach the project goals.
- Work autonomously
- Assemble and organize experiment results
- Establish protocols
- Rigor and autonomy
- Proficiency in molecular biology techniques (cloning, CRISPR), biochemistry and cell culture (P2)
- Ability to work as a team and be a team player
- Assemble experimental results and ability to present his/her work orally and in writing
- Good English skills
The postdoc will have the opportunity to participate in the implementation of a new team and will work under the supervision of the lab head in collaboration with the team members, the facilities personnel and national and international collaborators,
This is a DIM1 Health funded position.
The candidate will work in the « MalReg» team (https://www.i2bc.paris-saclay.fr/spip.php?article1532) in the genome biology department of the I2BC.
The I2BC is a University of Paris-Saclay/CNRS/CEA research unit situated in the research campus of Gif-sur-Yvette, 35km southwest of Paris. The campus is in close proximity to a natural park and is deserved by public transportation with direct access to Paris. The institute hosts around 750 people among 60 research teams and 14 state-of-the-art technical facilities.
Constraints and risks
Handling of level BSL3* pathogens and red blood cells.
We talk about it on Twitter!